{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "bad32605",
   "metadata": {},
   "source": [
    "# RAG Pipeline Exercise\n",
    "\n",
    "In this exercise you will build and **compare two simple Retrieval-Augmented Generation (RAG) pipelines**.\n",
    "\n",
    "You will work with a small collection of PDF documents (e.g. medical guidelines) and:\n",
    "\n",
    "1. Load and chunk the PDF documents.\n",
    "2. Create a vector index using **embedding model A** (local `BAAI/bge-m3`).\n",
    "3. Create a second index using **embedding model B** (e.g. OpenAI or Gemini embeddings).\n",
    "4. Implement a simple **retriever** and an **answering function** that calls an LLM with retrieved context.\n",
    "5. Automatically **generate questions** from the documents and use them to **compare two RAG configurations**.\n",
    "\n",
    "Cells marked with `# TODO` are **for students to implement**.\n",
    "Everything else is provided scaffolding."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "4ddf82e6",
   "metadata": {},
   "source": [
    "## 0. Setup & Imports"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "be93ec53",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/usr/local/python/3.12.1/lib/python3.12/site-packages/tqdm/auto.py:21: TqdmWarning: IProgress not found. Please update jupyter and ipywidgets. See https://ipywidgets.readthedocs.io/en/stable/user_install.html\n",
      "  from .autonotebook import tqdm as notebook_tqdm\n"
     ]
    }
   ],
   "source": [
    "# TODO (easy): skim the imports and make sure you understand what each library is used for.\n",
    "\n",
    "from dotenv import load_dotenv\n",
    "import os\n",
    "import glob\n",
    "from PyPDF2 import PdfReader\n",
    "from langchain_text_splitters import RecursiveCharacterTextSplitter\n",
    "import faiss\n",
    "from sentence_transformers import SentenceTransformer\n",
    "import pickle\n",
    "import random\n",
    "import numpy as np\n",
    "import pandas as pd\n",
    "\n",
    "# LLM / API clients (we will mainly use OpenAI here; Gemini can be added as a bonus)\n",
    "from openai import OpenAI"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "68f16980",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Load API keys from .env (you need to create this file once and add your keys)\n",
    "load_dotenv()\n",
    "\n",
    "deepinfra_key = os.getenv(\"DEEPINFRA_API_KEY\")\n",
    "openai_api_key = os.getenv(\"OPENAI_API_KEY\")\n",
    "google_api_key = os.getenv(\"GOOGLE_API_KEY\")\n",
    "anthropic_api_key = os.getenv(\"ANTHROPIC_API_KEY\")\n",
    "\n",
    "# For this exercise we mainly use OpenAI for both embeddings (RAG B) and chat completions.\n",
    "assert openai_api_key is not None, \"Please set OPENAI_API_KEY in your .env file.\"\n",
    "openai_client = OpenAI(api_key=openai_api_key)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "23ebcf52",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Make pandas show the full table and full cell content\n",
    "pd.set_option(\"display.max_rows\", None)       # show all rows\n",
    "pd.set_option(\"display.max_columns\", None)    # show all columns\n",
    "pd.set_option(\"display.max_colwidth\", None)   # don't truncate cell text"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "fba2719d",
   "metadata": {},
   "source": [
    "## 1. Load PDF documents\n",
    "\n",
    "We assume there is a `data/` folder containing one or more PDF files.\n",
    "\n",
    "**Task:** implement `load_pdfs(glob_path)` so that it:\n",
    "- Iterates over all PDF files matching `glob_path`\n",
    "- Reads them with `PdfReader`\n",
    "- Concatenates the text of all pages into **one long string**."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "d8abcb21",
   "metadata": {},
   "outputs": [],
   "source": [
    "def load_pdfs(glob_path: str = \"data/*.pdf\") -> str:\n",
    "    \"\"\"Load all PDFs matching the pattern and return their combined text.\n",
    "\n",
    "    TODO:\n",
    "    - Use `glob.glob(glob_path)` to iterate over file paths\n",
    "    - For each file, open it in binary mode and create a `PdfReader`\n",
    "    - Loop over `reader.pages` and extract text with the extract_text() function\n",
    "    - Concatenate everything into a single string `text`\n",
    "    - Be robust: skip pages where `extract_text()` returns None\n",
    "    \"\"\"\n",
    "    # YOUR CODE HERE\n",
    "    text = \"\"\n",
    "    for pdf_path in glob.glob(glob_path):\n",
    "        with open(pdf_path, \"rb\") as f:\n",
    "            reader = PdfReader(f)\n",
    "            for page in reader.pages:\n",
    "                page_text = page.extract_text()\n",
    "                if page_text:\n",
    "                    text += \" \" + page_text\n",
    "    return text\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "416c3ad0",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of characters: 279338\n",
      "Preview:  High and normal protein diets improve body composition and \n",
      "glucose control in adults with type 2 diabetes: A randomized \n",
      "trial\n",
      "Julianne G. Clina1, R. Drew Sayer1,3, Zhaoxing Pan2, Caroline W. Cohen3, Michael T. \n",
      "McDermott4, Victoria A. Catenacci4, Holly R. Wyatt1,5, James O. Hill1\n",
      "1Department of Nutrition Sciences, University of Alabama at Birmingham\n",
      "2Department of Pediatrics, University of Colorado Anschutz Medical Campus\n",
      "3Department of Family and Community Medicine, University of Alabama at \n"
     ]
    }
   ],
   "source": [
    "# Run once and inspect\n",
    "raw_text = load_pdfs(\"data/*.pdf\")\n",
    "print(\"Number of characters:\", len(raw_text))\n",
    "print(\"Preview:\", raw_text[:500])"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "5c0c5a14",
   "metadata": {},
   "source": [
    "## 2. Chunk the text\n",
    "\n",
    "We will split the long text into overlapping chunks.\n",
    "\n",
    "Later you can **experiment** with different `chunk_size` and `chunk_overlap` to see how it affects retrieval.\n",
    "\n",
    "**Task:** start with the given parameters, run once, then try at least one alternative configuration and note the effects."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "a4e3f802",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "RAG A: 157 chunks produced, first chunk length = 1954\n",
      "RAG B: 315 chunks produced, first chunk length = 981\n"
     ]
    }
   ],
   "source": [
    "# Base configuration (RAG A)\n",
    "chunk_size_a = 2000\n",
    "chunk_overlap_a = 200\n",
    "\n",
    "splitter_a = RecursiveCharacterTextSplitter(\n",
    "    chunk_size=chunk_size_a,\n",
    "    chunk_overlap=chunk_overlap_a\n",
    ")\n",
    "\n",
    "chunks_a = splitter_a.split_text(raw_text)\n",
    "print(f\"RAG A: {len(chunks_a)} chunks produced, first chunk length = {len(chunks_a[0])}\")\n",
    "\n",
    "# TODO (mini-experiment): change chunk_size / chunk_overlap for RAG B and compare\n",
    "chunk_size_b = 1000   # e.g. smaller chunks\n",
    "chunk_overlap_b = 100\n",
    "\n",
    "splitter_b = RecursiveCharacterTextSplitter(\n",
    "    chunk_size=chunk_size_b,\n",
    "    chunk_overlap=chunk_overlap_b\n",
    ")\n",
    "\n",
    "chunks_b = splitter_b.split_text(raw_text)\n",
    "print(f\"RAG B: {len(chunks_b)} chunks produced, first chunk length = {len(chunks_b[0])}\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ec3511f4",
   "metadata": {},
   "source": [
    "## 3. Create embeddings and a FAISS index\n",
    "\n",
    "We start with **Embedding model A: `BAAI/bge-small-en`** using `sentence-transformers`.\n",
    "\n",
    "Then, as an optional extension, you can build **Embedding model B** using OpenAI or Gemini and compare.\n",
    "\n",
    "To keep the exercise manageable, the base version only **requires** BGE."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "b519161f",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Embedding dimensionality (A): 384\n",
      "FAISS index (A) size: 157\n"
     ]
    }
   ],
   "source": [
    "# Embedding model A (local)\n",
    "model_name_a = \"BAAI/bge-small-en\"\n",
    "embedder_a = SentenceTransformer(model_name_a)\n",
    "\n",
    "# Compute embeddings for all chunks of configuration A\n",
    "embeddings_a = embedder_a.encode(chunks_a, convert_to_numpy=True)\n",
    "\n",
    "dimensions_a = embeddings_a.shape[1]\n",
    "print(\"Embedding dimensionality (A):\", dimensions_a)\n",
    "\n",
    "index_a = faiss.IndexFlatL2(dimensions_a)\n",
    "index_a.add(embeddings_a)\n",
    "print(\"FAISS index (A) size:\", index_a.ntotal)\n",
    "\n",
    "# Persist index/chunks if you like (optional)\n",
    "os.makedirs(\"faiss\", exist_ok=True)\n",
    "faiss.write_index(index_a, \"faiss/faiss_index_a.index\")\n",
    "with open(\"faiss/chunks_a.pkl\", \"wb\") as f:\n",
    "    pickle.dump(chunks_a, f)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "77271916",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "FAISS index (B) size: 315\n"
     ]
    }
   ],
   "source": [
    "# Embedding model B using OpenAI embeddings.\n",
    "\n",
    "# TODO:\n",
    "# - Use `openai_client.embeddings.create(...)` to compute embeddings for `chunks_b`\n",
    "# - Create a second FAISS index `index_b`\n",
    "# - Make sure to check the dimensionality from the first embedding vector\n",
    "\n",
    "# Example sketch (not complete, adapt & run if you have API access):\n",
    "# Initialize OpenAI client\n",
    "openai_client = OpenAI(api_key=openai_api_key)\n",
    "response = openai_client.embeddings.create(\n",
    "     model=\"text-embedding-3-small\",\n",
    "    input=chunks_b\n",
    ")\n",
    "embeddings_b = np.array([item.embedding for item in response.data])\n",
    "dim_b = embeddings_b.shape[1]\n",
    "index_b = faiss.IndexFlatL2(dim_b)\n",
    "index_b.add(embeddings_b)\n",
    "print(\"FAISS index (B) size:\", index_b.ntotal)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "0339224e",
   "metadata": {},
   "source": [
    "## 4. Implement a simple retriever\n",
    "\n",
    "We now implement a generic retrieval function that:\n",
    "1. Embeds the query.\n",
    "2. Searches the FAISS index.\n",
    "3. Returns the corresponding text chunks.\n",
    "\n",
    "We implement it for configuration A. If you built configuration B, you can reuse the same function."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "aa6fbf82",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of retrieved chunks: 3\n",
      "Preview of first chunk: likely to be normal). [NICE 2017] \n",
      "1.2 O bjective tests f or diagnosing asthma in adul ts, \n",
      "young pe ople and childr en ag ed 5 to 16 wi th a \n",
      "histor y sug gestive of asthma \n",
      "Adults \n",
      "See also algorit hm A f or a summar y of objectiv e tests for diagnosing ast hma in adult s and \n",
      "young people (aged o ver 16 y ears) wit h a hist ory suggesting ast hma. Asthma: diagnosis, monit oring and chr onic ast\n"
     ]
    }
   ],
   "source": [
    "def retrieve_texts(query: str, k: int, index, chunks, embedder) -> list:\n",
    "    \"\"\"Return the top-k most similar chunks for a query.\n",
    "\n",
    "    TODO (students):\n",
    "    - Encode the query with `embedder.encode(...)`\n",
    "    - Call `index.search(query_embedding, k)`\n",
    "    - Use the returned indices to select the chunks\n",
    "    - Return a list of strings (chunks)\n",
    "    \"\"\"\n",
    "    # YOUR CODE HERE\n",
    "    query_emb = embedder.encode([query], convert_to_numpy=True)\n",
    "    distances, indices = index.search(query_emb, k)\n",
    "    retrieved = [chunks[i] for i in indices[0]]\n",
    "    return retrieved\n",
    "\n",
    "# Quick sanity check\n",
    "test_query = \"What is the most important factor in diagnosing asthma?\"\n",
    "retrieved_text = retrieve_texts(test_query, k=3, index=index_a, chunks=chunks_a, embedder=embedder_a)\n",
    "print(\"Number of retrieved chunks:\", len(retrieved_text))\n",
    "print(\"Preview of first chunk:\", retrieved_text[0][:400])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "84287470",
   "metadata": {},
   "outputs": [],
   "source": [
    "def openai_embed_query(query: str) -> np.ndarray:\n",
    "    \"\"\"\n",
    "    Compute an OpenAI embedding for a single query string and\n",
    "    return it as a NumPy array of shape (1, dim).\n",
    "    \"\"\"\n",
    "    resp = openai_client.embeddings.create(\n",
    "        model=\"text-embedding-3-small\",\n",
    "        input=[query]  # list with one string\n",
    "    )\n",
    "    vec = np.array(resp.data[0].embedding, dtype=\"float32\")\n",
    "    return vec.reshape(1, -1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "68ab8b40",
   "metadata": {},
   "outputs": [],
   "source": [
    "def retrieve_texts_b(query: str, k: int, index, chunks) -> list:\n",
    "    \"\"\"\n",
    "    Retrieve top-k chunks using OpenAI embeddings for the query.\n",
    "    \"\"\"\n",
    "    query_emb = openai_embed_query(query)  # shape (1, dim)\n",
    "    distances, indices = index.search(query_emb, k)\n",
    "    retrieved = [chunks[i] for i in indices[0]]\n",
    "    return retrieved"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f646fdc6",
   "metadata": {},
   "source": [
    "## 5. Implement `answer_query` using an LLM\n",
    "\n",
    "Now we build the actual RAG call:\n",
    "\n",
    "1. Use `retrieve_texts` to get top-`k` chunks.\n",
    "2. Concatenate them into a context string.\n",
    "3. Build a prompt that:\n",
    "   - shows the context\n",
    "   - asks the model to answer the user question based **only** on this context.\n",
    "4. Call the OpenAI chat completion API.\n",
    "\n",
    "This is the **core RAG function**."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "0d94610c",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "RAG answer: The provided context does not specify a single most important factor in diagnosing asthma. It outlines various objective tests such as measuring blood eosinophil count, fractional exhaled nitric oxide (FeNO) levels, bronchodilator reversibility, and peak expiratory flow variability. Each of these tests plays a role in confirming the diagnosis based on specific criteria. Therefore, I do not know the most important factor in diagnosing asthma based on the context provided.\n"
     ]
    }
   ],
   "source": [
    "def answer_query_a(query: str, k: int, index, chunks, embedder, client: OpenAI) -> str:\n",
    "    \"\"\"RAG-style answer: retrieve context and ask an LLM.\n",
    "\n",
    "    TODO (students):\n",
    "    - Use `retrieve_texts` to get `k` relevant chunks.\n",
    "    - Join them into a single context string.\n",
    "    - Build a chat prompt that instructs the model to answer *only* using the context.\n",
    "    - Call `client.chat.completions.create(...)` with model `\"gpt-4o-mini\"` (or similar).\n",
    "    - Return the model's answer text.\n",
    "    \"\"\"\n",
    "    retrieved_chunks = retrieve_texts(query, k, index, chunks, embedder)\n",
    "    context = \"\\n\\n---\\n\\n\".join(retrieved_chunks)\n",
    "\n",
    "    system_prompt = (\n",
    "        \"You are a helpful assistant answering questions based ONLY on the provided context. \"\n",
    "        \"If the answer is not in the context, say that you do not know.\"\n",
    "    )\n",
    "\n",
    "    messages = [\n",
    "        {\"role\": \"system\", \"content\": system_prompt},\n",
    "        {\"role\": \"user\", \"content\": f\"Context:\\n{context}\\n\\nQuestion: {query}\"}\n",
    "    ]\n",
    "\n",
    "    completion = client.chat.completions.create(\n",
    "        model=\"gpt-4o-mini\",\n",
    "        messages=messages\n",
    "    )\n",
    "\n",
    "    return completion.choices[0].message.content.strip()\n",
    "\n",
    "# Quick manual test\n",
    "answer = answer_query_a(test_query, k=3, index=index_a, chunks=chunks_a, embedder=embedder_a, client=openai_client)\n",
    "print(\"RAG answer:\", answer)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "4b13aade",
   "metadata": {},
   "source": [
    "### Answer Function with the other embedding type"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "5994c414",
   "metadata": {},
   "outputs": [],
   "source": [
    "def answer_query_b(query: str, k: int, index, chunks, client: OpenAI) -> str:\n",
    "    \"\"\"\n",
    "    RAG-style answer for configuration B (OpenAI embeddings + chunking B).\n",
    "    \"\"\"\n",
    "    retrieved_chunks = retrieve_texts_b(query, k, index, chunks)\n",
    "    context = \"\\n\\n---\\n\\n\".join(retrieved_chunks)\n",
    "\n",
    "    system_prompt = (\n",
    "        \"You are a helpful assistant answering questions based ONLY on the provided context. \"\n",
    "        \"If the answer is not in the context, say that you do not know.\"\n",
    "    )\n",
    "\n",
    "    messages = [\n",
    "        {\"role\": \"system\", \"content\": system_prompt},\n",
    "        {\"role\": \"user\", \"content\": f\"Context:\\n{context}\\n\\nQuestion: {query}\"},\n",
    "    ]\n",
    "\n",
    "    completion = client.chat.completions.create(\n",
    "        model=\"gpt-4o-mini\",\n",
    "        messages=messages,\n",
    "    )\n",
    "\n",
    "    return completion.choices[0].message.content.strip()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7a86a92e",
   "metadata": {},
   "source": [
    "## 6. Generate questions from random chunks (automatic evaluation set)\n",
    "\n",
    "To compare two RAG configurations, we need **questions**.\n",
    "\n",
    "We will:\n",
    "- randomly sample a few chunks from the corpus,\n",
    "- ask an LLM to generate a **good question** whose answer is contained in the chunk.\n",
    "\n",
    "Then we can use these questionâ€“chunk pairs as a small evaluation set.\n",
    "\n",
    "We provide most of the implementation. Your job is mainly to:\n",
    "- inspect the code,\n",
    "- understand the prompt,\n",
    "- maybe tweak the number of chunks or retries."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "eb899fb6",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Q1: What are the key updates in the NICE guidelines for managing hypertension in adults, particularly concerning treatment targets, resistant hypertension, and referral criteria for very high blood pressure?\n",
      "  From chunk preview: blood pr essur e to lower tar gets in people wit h hyper tension (including t hose wit h type  2 \n",
      "diabet es). The updat ...\n",
      "\n",
      "Q2: What are the potential negative impacts of regular PEF monitoring on asthma control and quality of life for both adults and children, as identified by the committee's findings?\n",
      "  From chunk preview: 64 there was no clinically useful eff ect of t he monit oring in eit her adult s or childr en. The \n",
      "committ ee not ed th...\n",
      "\n",
      "Q3: How can local commissioners and healthcare providers effectively implement the Yellow Card Scheme while ensuring compliance with duties to eliminate discrimination, promote equality, and address environmental sustainability in asthma management?\n",
      "  From chunk preview: Agency using t he Yellow Car d Scheme . \n",
      "Local commissioners and pr oviders of healt hcare have a responsibility t o ena...\n",
      "\n",
      "Q4: What recent developments and recommendations have emerged in the management and diagnosis of hypertension, particularly concerning lower risk populations and individuals with type 2 diabetes, since the 2011 NICE guideline?\n",
      "  From chunk preview: prematur e morbidity and mor tality in t he w orld. It is a major risk f actor for str oke, \n",
      "myocardial inf arction, hea...\n",
      "\n",
      "Q5: How might the committee's recommendation to switch more patients to MART therapy, based on observed improvements in studies, impact treatment practices for asthma, particularly for children aged 5 to 11?\n",
      "  From chunk preview: applies her e. The r ecommendations ar e not based on a specific e vidence sear ch, but t he \n",
      "committ ee not ed that peo...\n",
      "\n"
     ]
    }
   ],
   "source": [
    "def generate_questions_for_random_chunks(chunks, num_chunks: int = 5, max_retries: int = 2):\n",
    "    selected_chunks = random.sample(chunks, num_chunks)\n",
    "    qa_pairs = []\n",
    "\n",
    "    for chunk in selected_chunks:\n",
    "        prompt = prompt = (\n",
    "            \"Based on the following text, generate an insightful question that covers its key content:\\n\\n\"\n",
    "            \"Text:\\n\" + chunk + \"\\n\\n\"\n",
    "            \"Question:\"\n",
    "        )\n",
    "\n",
    "        question = None\n",
    "        for attempt in range(max_retries):\n",
    "            try:\n",
    "                completion = openai_client.chat.completions.create(\n",
    "                    model=\"gpt-4o-mini\",\n",
    "                    messages=[{\"role\": \"user\", \"content\": prompt}]\n",
    "                )\n",
    "                question = completion.choices[0].message.content.strip()\n",
    "                if question:\n",
    "                    break\n",
    "            except Exception as e:\n",
    "                print(\"Error while generating question, retrying...\", e)\n",
    "\n",
    "        if question is None:\n",
    "            question = \"Error: could not generate question.\"\n",
    "\n",
    "        qa_pairs.append((chunk, question))\n",
    "\n",
    "    return qa_pairs\n",
    "\n",
    "questions = generate_questions_for_random_chunks(chunks_a, num_chunks=5, max_retries=2)\n",
    "for i, (chunk, q) in enumerate(questions, 1):\n",
    "    print(f\"Q{i}: {q}\\n  From chunk preview: {chunk[:120]}...\\n\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "3fd0eaf5",
   "metadata": {},
   "source": [
    "## 7. Compare two RAG configurations\n",
    "\n",
    "Now we can:\n",
    "- Use the generated questions,\n",
    "- Answer them with RAG configuration A (BGE + chunking A),\n",
    "- (Optional) Answer them with RAG configuration B (e.g. different chunking and/or different embeddings),\n",
    "- Compare the answers qualitatively.\n",
    "\n",
    "To keep the exercise manageable, we start with config A only.\n",
    "If you implemented config B, reuse `answer_query` with `index_b`, `chunks_b`, and your second embedder."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "a292474a",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Question: What are the key updates in the NICE guidelines for managing hypertension in adults, particularly concerning treatment targets, resistant hypertension, and referral criteria for very high blood pressure?\n",
      "Answer A: I do not know.\n",
      "Source chunk preview: blood pr essur e to lower tar gets in people wit h hyper tension (including t hose wit h type  2 \n",
      "diabet es). The updat ed guideline mak es new r ecom ...\n",
      "------------------------------------------------------------\n",
      "Question: What are the potential negative impacts of regular PEF monitoring on asthma control and quality of life for both adults and children, as identified by the committee's findings?\n",
      "Answer A: The committee identified that regular PEF monitoring was associated with worse quality-of-life parameters in adults, possibly due to regular monitoring inducing anxiety if PEF levels were not consistently high. Additionally, PEF monitoring was linked to an increase in asthma attacks in both adults and children, which is considered a disadvantage of regular monitoring. Overall, the findings suggest that regular PEF monitoring could negatively impact asthma control and quality of life by causing anxiety and potentially increasing the frequency of asthma attacks.\n",
      "Source chunk preview: 64 there was no clinically useful eff ect of t he monit oring in eit her adult s or childr en. The \n",
      "committ ee not ed that t he int erventions w ere c ...\n",
      "------------------------------------------------------------\n",
      "Question: How can local commissioners and healthcare providers effectively implement the Yellow Card Scheme while ensuring compliance with duties to eliminate discrimination, promote equality, and address environmental sustainability in asthma management?\n",
      "Answer A: Local commissioners and healthcare providers can effectively implement the Yellow Card Scheme by applying the guidelines within the context of local and national priorities for funding and service development. They should ensure that their practices are aligned with their duties to eliminate unlawful discrimination, advance equality of opportunity, and reduce health inequalities. Furthermore, they have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations whenever possible.\n",
      "Source chunk preview: Agency using t he Yellow Car d Scheme . \n",
      "Local commissioners and pr oviders of healt hcare have a responsibility t o enable t he \n",
      "guideline t o be app ...\n",
      "------------------------------------------------------------\n",
      "Question: What recent developments and recommendations have emerged in the management and diagnosis of hypertension, particularly concerning lower risk populations and individuals with type 2 diabetes, since the 2011 NICE guideline?\n",
      "Answer A: The recent developments and recommendations in the management and diagnosis of hypertension, particularly concerning lower-risk populations and individuals with type 2 diabetes, include:\n",
      "\n",
      "1. **Lifestyle Interventions**: Recommendations emphasize lifestyle advice for people with suspected or diagnosed hypertension, suggesting that healthy diet and regular exercise can reduce blood pressure.\n",
      "\n",
      "2. **Antihypertensive Treatment Thresholds**: For individuals with type 2 diabetes, antihypertensive drug treatment is suggested if lifestyle interventions alone do not reduce blood pressure below specified thresholds (140/80 mmHg or 130/80 mmHg in the presence of certain diseases). However, this recommendation was based on limited evidence from small studies.\n",
      "\n",
      "3. **Clinical Judgement for Older Adults**: The guidelines suggest the need for clinical judgement when deciding on treatment options for older adults, especially those who are frail or have multiple comorbidities, with a recommended treatment threshold for this age group set at 150/90 mmHg or lower.\n",
      "\n",
      "4. **Cuff Size for Blood Pressure Measurement**: Information on cuff size for measuring blood pressure was moved to avoid repetition, indicating an emphasis on correct measuring techniques to improve accuracy.\n",
      "\n",
      "5. **Use of HbA1c for Diabetes Management**: The guidelines have replaced plasma glucose testing with glycated haemoglobin (HbA1c) to reflect current practice better.\n",
      "\n",
      "6. **Warnings About Salt Substitutes**: There has been an added note regarding the risks of salt substitutes for specific groups, including older adults and those with diabetes.\n",
      "\n",
      "These updates reflect a shift in focus toward more personalized treatment approaches, considering individual risk factors, especially in populations like those with type 2 diabetes or the elderly.\n",
      "Source chunk preview: prematur e morbidity and mor tality in t he w orld. It is a major risk f actor for str oke, \n",
      "myocardial inf arction, hear t failure, chr onic kidne y  ...\n",
      "------------------------------------------------------------\n",
      "Question: How might the committee's recommendation to switch more patients to MART therapy, based on observed improvements in studies, impact treatment practices for asthma, particularly for children aged 5 to 11?\n",
      "Answer A: The committee's recommendation to switch more patients to MART therapy is expected to result in a greater number of children with asthma being transitioned to MART than to other treatment options. This change should not be disruptive, as MART is already in use, and it is anticipated to bring advantages in terms of reducing asthma attacks. For children aged 5 to 11, the recommendation reflects a shift in practice that aligns with the evidence supporting the benefits of MART, particularly for those whose asthma is uncontrolled on regular paediatric low-dose ICS plus SABA as needed. The changes in practice are likely to be modest and cost-effective for the NHS, promoting better asthma management and potentially improving outcomes for this age group.\n",
      "Source chunk preview: applies her e. The r ecommendations ar e not based on a specific e vidence sear ch, but t he \n",
      "committ ee not ed that people in t he MART studies r evi ...\n",
      "------------------------------------------------------------\n"
     ]
    }
   ],
   "source": [
    "def answer_generated_questions_a(question_tuples, k, index, chunks, embedder, client):\n",
    "    results = []\n",
    "    for chunk, question in question_tuples:\n",
    "        answer = answer_query_a(question, k, index, chunks, embedder, client)\n",
    "        results.append({\n",
    "            \"chunk\": chunk,\n",
    "            \"question\": question,\n",
    "            \"answer\": answer\n",
    "        })\n",
    "    return results\n",
    "\n",
    "results_a = answer_generated_questions_a(\n",
    "    questions,\n",
    "    k=5,\n",
    "    index=index_a,\n",
    "    chunks=chunks_a,\n",
    "    embedder=embedder_a,\n",
    "    client=openai_client,\n",
    ")\n",
    "\n",
    "for item in results_a:\n",
    "    print(\"Question:\", item[\"question\"])\n",
    "    print(\"Answer A:\", item[\"answer\"])\n",
    "    print(\"Source chunk preview:\", item[\"chunk\"][:150], \"...\")\n",
    "    print(\"-\" * 60)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "2ec212b7",
   "metadata": {},
   "source": [
    "### Extension: add RAG B and create a comparison table\n",
    "\n",
    "If you implemented a second configuration (e.g. different chunking + OpenAI embeddings):\n",
    "\n",
    "1. Build `index_b` using OpenAI embeddings and `chunks_b`.\n",
    "2. Implement `openai_embed_query`, `retrieve_texts_b`, and `answer_query_b`.\n",
    "3. Run `results_b = answer_generated_questions_b(questions, k=5, index=index_b, chunks=chunks_b, client=openai_client)`.\n",
    "4. For each question, compare:\n",
    "   - Which answer is more complete / specific?\n",
    "   - Which one is better grounded in the source chunk?\n",
    "5. Summarise your findings in a short **markdown cell** or a small table.\n",
    "\n",
    "---\n",
    "\n",
    "This concludes the core RAG exercise.\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "faa74961",
   "metadata": {},
   "outputs": [],
   "source": [
    "def answer_generated_questions_b(question_tuples, k, index, chunks, client):\n",
    "    \"\"\"\n",
    "    Use RAG B to answer a list of (chunk, question) pairs.\n",
    "    \"\"\"\n",
    "    results = []\n",
    "    for chunk, question in question_tuples:\n",
    "        answer = answer_query_b(question, k, index, chunks, client)\n",
    "        results.append({\n",
    "            \"chunk\": chunk,\n",
    "            \"question\": question,\n",
    "            \"answer\": answer,\n",
    "        })\n",
    "    return results\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "e9ee1310",
   "metadata": {},
   "outputs": [],
   "source": [
    "results_b = answer_generated_questions_b(\n",
    "    questions,\n",
    "    k=5,\n",
    "    index=index_b,\n",
    "    chunks=chunks_b,\n",
    "    client=openai_client,\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "bc18c46e",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Question</th>\n",
       "      <th>Answer A (BGE + config A)</th>\n",
       "      <th>Answer B (OpenAI + config B)</th>\n",
       "      <th>Source chunk (A) preview</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>What are the key updates in the NICE guidelines for managing hypertension in adults, particularly concerning treatment targets, resistant hypertension, and referral criteria for very high blood pressure?</td>\n",
       "      <td>I do not know.</td>\n",
       "      <td>The key updates in the NICE guidelines for managing hypertension in adults include:\\n\\n1. **Treatment Targets**: New studies have led to updated recommendations on how to manage blood pressure in lower risk populations and the thresholds for diagnosis and treatment targets for people with hypertension, including those with type 2 diabetes.\\n\\n2. **Resistant Hypertension**: Recommendations have been updated based on new data to address the challenges of treating resistant hypertension, which occurs when more than three drugs are needed to manage hypertension effectively.\\n\\n3. **Referral Criteria for Very High Blood Pressure**: There is ongoing uncertainty in current practice regarding which individuals with symptomatic very high blood pressure should be referred for specialist review.\\n\\nThese updates aim to improve care and reduce variations in current practice related to the management of hypertension.</td>\n",
       "      <td>blood pr essur e to lower tar gets in people wit h hyper tension (including t hose wit h type  2 \\ndiabet es). The updat ed guideline mak es new r ecommendations in t hese ar eas, based on \\nthe evidenc...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>What are the potential negative impacts of regular PEF monitoring on asthma control and quality of life for both adults and children, as identified by the committee's findings?</td>\n",
       "      <td>The committee identified that regular PEF monitoring was associated with worse quality-of-life parameters in adults, possibly due to regular monitoring inducing anxiety if PEF levels were not consistently high. Additionally, PEF monitoring was linked to an increase in asthma attacks in both adults and children, which is considered a disadvantage of regular monitoring. Overall, the findings suggest that regular PEF monitoring could negatively impact asthma control and quality of life by causing anxiety and potentially increasing the frequency of asthma attacks.</td>\n",
       "      <td>The committee identified several potential negative impacts of regular PEF monitoring on asthma control and quality of life for both adults and children:\\n\\n1. **Worse Quality-of-Life Parameters**: Regular PEF monitoring was associated with worse quality-of-life parameters, potentially due to the anxiety induced when PEF measurements are not consistently high.\\n\\n2. **Anxiety Induction**: The act of regular monitoring could induce anxiety in some individuals regarding their condition.\\n\\n3. **Inconvenience**: Making regular measurements can be inconvenient for patients.\\n\\n4. **Increased Asthma Attacks**: In both adults and children, PEF monitoring was associated with an increase in asthma attacks, which the committee found difficult to explain, as monitoring itself seems unlikely to worsen asthma.\\n\\n5. **Lack of Reduction in Hospitalization or Time Off**: Despite the potential for quicker identification and appropriate early treatment of attacks, the expected benefits such as a reduction in hospitalization or time off work or school were not observed.\\n\\nThese factors led the committee to recommend against routine PEF monitoring, except for a minority of people who might benefit from it.</td>\n",
       "      <td>64 there was no clinically useful eff ect of t he monit oring in eit her adult s or childr en. The \\ncommitt ee not ed that t he int erventions w ere comple x, as t hey assessed t he eff ects not \\njust...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>How can local commissioners and healthcare providers effectively implement the Yellow Card Scheme while ensuring compliance with duties to eliminate discrimination, promote equality, and address environmental sustainability in asthma management?</td>\n",
       "      <td>Local commissioners and healthcare providers can effectively implement the Yellow Card Scheme by applying the guidelines within the context of local and national priorities for funding and service development. They should ensure that their practices are aligned with their duties to eliminate unlawful discrimination, advance equality of opportunity, and reduce health inequalities. Furthermore, they have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations whenever possible.</td>\n",
       "      <td>Local commissioners and healthcare providers can effectively implement the Yellow Card Scheme by enabling the application of the guideline in the context of local and national priorities for funding and developing services. They should ensure compliance with their duties to eliminate unlawful discrimination, advance equality of opportunity, and reduce health inequalities by integrating these principles into their decision-making processes and practices. Additionally, they should promote an environmentally sustainable health and care system by assessing and reducing the environmental impact of implementing NICE recommendations wherever possible. This approach will help align the implementation of the Yellow Card Scheme with broader health management goals while adhering to legal and ethical responsibilities.</td>\n",
       "      <td>Agency using t he Yellow Car d Scheme . \\nLocal commissioners and pr oviders of healt hcare have a responsibility t o enable t he \\nguideline t o be applied when individual pr ofessionals and people usi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>What recent developments and recommendations have emerged in the management and diagnosis of hypertension, particularly concerning lower risk populations and individuals with type 2 diabetes, since the 2011 NICE guideline?</td>\n",
       "      <td>The recent developments and recommendations in the management and diagnosis of hypertension, particularly concerning lower-risk populations and individuals with type 2 diabetes, include:\\n\\n1. **Lifestyle Interventions**: Recommendations emphasize lifestyle advice for people with suspected or diagnosed hypertension, suggesting that healthy diet and regular exercise can reduce blood pressure.\\n\\n2. **Antihypertensive Treatment Thresholds**: For individuals with type 2 diabetes, antihypertensive drug treatment is suggested if lifestyle interventions alone do not reduce blood pressure below specified thresholds (140/80 mmHg or 130/80 mmHg in the presence of certain diseases). However, this recommendation was based on limited evidence from small studies.\\n\\n3. **Clinical Judgement for Older Adults**: The guidelines suggest the need for clinical judgement when deciding on treatment options for older adults, especially those who are frail or have multiple comorbidities, with a recommended treatment threshold for this age group set at 150/90 mmHg or lower.\\n\\n4. **Cuff Size for Blood Pressure Measurement**: Information on cuff size for measuring blood pressure was moved to avoid repetition, indicating an emphasis on correct measuring techniques to improve accuracy.\\n\\n5. **Use of HbA1c for Diabetes Management**: The guidelines have replaced plasma glucose testing with glycated haemoglobin (HbA1c) to reflect current practice better.\\n\\n6. **Warnings About Salt Substitutes**: There has been an added note regarding the risks of salt substitutes for specific groups, including older adults and those with diabetes.\\n\\nThese updates reflect a shift in focus toward more personalized treatment approaches, considering individual risk factors, especially in populations like those with type 2 diabetes or the elderly.</td>\n",
       "      <td>Recent developments and recommendations in the management and diagnosis of hypertension since the 2011 NICE guideline include:\\n\\n1. Updates on the optimal method and threshold for the diagnosis of hypertension.\\n2. New strategies for managing blood pressure in lower risk populations.\\n3. Recommendations aimed at reducing blood pressure to lower targets for individuals with hypertension, including those with type 2 diabetes.\\n\\nThe updated guidelines emphasize discussing treatment preferences with patients and encouraging lifestyle changes. Additionally, there were amendments to clarify recommendations for adults over 80 with stage 1 hypertension and to include those with type 2 diabetes unless other NICE guidelines indicate different treatment approaches. \\n\\nThe committee was also mindful that some evidence suggested lower treatment thresholds in individuals with type 2 diabetes did not significantly reduce cardiovascular events in those without additional risk factors. Thus, they concluded that evidence for lower treatment thresholds for this group was insufficient.</td>\n",
       "      <td>prematur e morbidity and mor tality in t he w orld. It is a major risk f actor for str oke, \\nmyocardial inf arction, hear t failure, chr onic kidne y disease, cognitiv e decline and \\nprematur e deat h...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>How might the committee's recommendation to switch more patients to MART therapy, based on observed improvements in studies, impact treatment practices for asthma, particularly for children aged 5 to 11?</td>\n",
       "      <td>The committee's recommendation to switch more patients to MART therapy is expected to result in a greater number of children with asthma being transitioned to MART than to other treatment options. This change should not be disruptive, as MART is already in use, and it is anticipated to bring advantages in terms of reducing asthma attacks. For children aged 5 to 11, the recommendation reflects a shift in practice that aligns with the evidence supporting the benefits of MART, particularly for those whose asthma is uncontrolled on regular paediatric low-dose ICS plus SABA as needed. The changes in practice are likely to be modest and cost-effective for the NHS, promoting better asthma management and potentially improving outcomes for this age group.</td>\n",
       "      <td>The committee's recommendation to switch more patients to MART therapy is expected to result in more children aged 5 to 11 being switched to MART than to other treatment options. This change should not be disruptive, as MART is already in use. The recommendation is based on evidence showing that MART is superior to both regular moderate-dose ICS plus SABA and regular low-dose ICS/L ABA plus SABA, leading to fewer exacerbations, reduced need for reliever inhalers, and fewer adverse events. Overall, the changes are considered modest and cost-effective for the NHS, with expected advantages in reducing asthma attacks among children. However, MART will not be suitable for all children, and there are recommendations in place for those who are unable to manage the MART regimen, which aligns with current practices.</td>\n",
       "      <td>applies her e. The r ecommendations ar e not based on a specific e vidence sear ch, but t he \\ncommitt ee not ed that people in t he MART studies r eview ed for recommendations 1 .7.3 to \\n1.7.6 (see t ...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                                                                                                                                                                                                Question  \\\n",
       "0                                            What are the key updates in the NICE guidelines for managing hypertension in adults, particularly concerning treatment targets, resistant hypertension, and referral criteria for very high blood pressure?   \n",
       "1                                                                       What are the potential negative impacts of regular PEF monitoring on asthma control and quality of life for both adults and children, as identified by the committee's findings?   \n",
       "2  How can local commissioners and healthcare providers effectively implement the Yellow Card Scheme while ensuring compliance with duties to eliminate discrimination, promote equality, and address environmental sustainability in asthma management?   \n",
       "3                         What recent developments and recommendations have emerged in the management and diagnosis of hypertension, particularly concerning lower risk populations and individuals with type 2 diabetes, since the 2011 NICE guideline?   \n",
       "4                                            How might the committee's recommendation to switch more patients to MART therapy, based on observed improvements in studies, impact treatment practices for asthma, particularly for children aged 5 to 11?   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Answer A (BGE + config A)  \\\n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         I do not know.   \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 The committee identified that regular PEF monitoring was associated with worse quality-of-life parameters in adults, possibly due to regular monitoring inducing anxiety if PEF levels were not consistently high. Additionally, PEF monitoring was linked to an increase in asthma attacks in both adults and children, which is considered a disadvantage of regular monitoring. Overall, the findings suggest that regular PEF monitoring could negatively impact asthma control and quality of life by causing anxiety and potentially increasing the frequency of asthma attacks.   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Local commissioners and healthcare providers can effectively implement the Yellow Card Scheme by applying the guidelines within the context of local and national priorities for funding and service development. They should ensure that their practices are aligned with their duties to eliminate unlawful discrimination, advance equality of opportunity, and reduce health inequalities. Furthermore, they have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations whenever possible.   \n",
       "3  The recent developments and recommendations in the management and diagnosis of hypertension, particularly concerning lower-risk populations and individuals with type 2 diabetes, include:\\n\\n1. **Lifestyle Interventions**: Recommendations emphasize lifestyle advice for people with suspected or diagnosed hypertension, suggesting that healthy diet and regular exercise can reduce blood pressure.\\n\\n2. **Antihypertensive Treatment Thresholds**: For individuals with type 2 diabetes, antihypertensive drug treatment is suggested if lifestyle interventions alone do not reduce blood pressure below specified thresholds (140/80 mmHg or 130/80 mmHg in the presence of certain diseases). However, this recommendation was based on limited evidence from small studies.\\n\\n3. **Clinical Judgement for Older Adults**: The guidelines suggest the need for clinical judgement when deciding on treatment options for older adults, especially those who are frail or have multiple comorbidities, with a recommended treatment threshold for this age group set at 150/90 mmHg or lower.\\n\\n4. **Cuff Size for Blood Pressure Measurement**: Information on cuff size for measuring blood pressure was moved to avoid repetition, indicating an emphasis on correct measuring techniques to improve accuracy.\\n\\n5. **Use of HbA1c for Diabetes Management**: The guidelines have replaced plasma glucose testing with glycated haemoglobin (HbA1c) to reflect current practice better.\\n\\n6. **Warnings About Salt Substitutes**: There has been an added note regarding the risks of salt substitutes for specific groups, including older adults and those with diabetes.\\n\\nThese updates reflect a shift in focus toward more personalized treatment approaches, considering individual risk factors, especially in populations like those with type 2 diabetes or the elderly.   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   The committee's recommendation to switch more patients to MART therapy is expected to result in a greater number of children with asthma being transitioned to MART than to other treatment options. This change should not be disruptive, as MART is already in use, and it is anticipated to bring advantages in terms of reducing asthma attacks. For children aged 5 to 11, the recommendation reflects a shift in practice that aligns with the evidence supporting the benefits of MART, particularly for those whose asthma is uncontrolled on regular paediatric low-dose ICS plus SABA as needed. The changes in practice are likely to be modest and cost-effective for the NHS, promoting better asthma management and potentially improving outcomes for this age group.   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Answer B (OpenAI + config B)  \\\n",
       "0                                                                                                                                                                                                                                                                                                     The key updates in the NICE guidelines for managing hypertension in adults include:\\n\\n1. **Treatment Targets**: New studies have led to updated recommendations on how to manage blood pressure in lower risk populations and the thresholds for diagnosis and treatment targets for people with hypertension, including those with type 2 diabetes.\\n\\n2. **Resistant Hypertension**: Recommendations have been updated based on new data to address the challenges of treating resistant hypertension, which occurs when more than three drugs are needed to manage hypertension effectively.\\n\\n3. **Referral Criteria for Very High Blood Pressure**: There is ongoing uncertainty in current practice regarding which individuals with symptomatic very high blood pressure should be referred for specialist review.\\n\\nThese updates aim to improve care and reduce variations in current practice related to the management of hypertension.   \n",
       "1  The committee identified several potential negative impacts of regular PEF monitoring on asthma control and quality of life for both adults and children:\\n\\n1. **Worse Quality-of-Life Parameters**: Regular PEF monitoring was associated with worse quality-of-life parameters, potentially due to the anxiety induced when PEF measurements are not consistently high.\\n\\n2. **Anxiety Induction**: The act of regular monitoring could induce anxiety in some individuals regarding their condition.\\n\\n3. **Inconvenience**: Making regular measurements can be inconvenient for patients.\\n\\n4. **Increased Asthma Attacks**: In both adults and children, PEF monitoring was associated with an increase in asthma attacks, which the committee found difficult to explain, as monitoring itself seems unlikely to worsen asthma.\\n\\n5. **Lack of Reduction in Hospitalization or Time Off**: Despite the potential for quicker identification and appropriate early treatment of attacks, the expected benefits such as a reduction in hospitalization or time off work or school were not observed.\\n\\nThese factors led the committee to recommend against routine PEF monitoring, except for a minority of people who might benefit from it.   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                        Local commissioners and healthcare providers can effectively implement the Yellow Card Scheme by enabling the application of the guideline in the context of local and national priorities for funding and developing services. They should ensure compliance with their duties to eliminate unlawful discrimination, advance equality of opportunity, and reduce health inequalities by integrating these principles into their decision-making processes and practices. Additionally, they should promote an environmentally sustainable health and care system by assessing and reducing the environmental impact of implementing NICE recommendations wherever possible. This approach will help align the implementation of the Yellow Card Scheme with broader health management goals while adhering to legal and ethical responsibilities.   \n",
       "3                                                                                                                             Recent developments and recommendations in the management and diagnosis of hypertension since the 2011 NICE guideline include:\\n\\n1. Updates on the optimal method and threshold for the diagnosis of hypertension.\\n2. New strategies for managing blood pressure in lower risk populations.\\n3. Recommendations aimed at reducing blood pressure to lower targets for individuals with hypertension, including those with type 2 diabetes.\\n\\nThe updated guidelines emphasize discussing treatment preferences with patients and encouraging lifestyle changes. Additionally, there were amendments to clarify recommendations for adults over 80 with stage 1 hypertension and to include those with type 2 diabetes unless other NICE guidelines indicate different treatment approaches. \\n\\nThe committee was also mindful that some evidence suggested lower treatment thresholds in individuals with type 2 diabetes did not significantly reduce cardiovascular events in those without additional risk factors. Thus, they concluded that evidence for lower treatment thresholds for this group was insufficient.   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                        The committee's recommendation to switch more patients to MART therapy is expected to result in more children aged 5 to 11 being switched to MART than to other treatment options. This change should not be disruptive, as MART is already in use. The recommendation is based on evidence showing that MART is superior to both regular moderate-dose ICS plus SABA and regular low-dose ICS/L ABA plus SABA, leading to fewer exacerbations, reduced need for reliever inhalers, and fewer adverse events. Overall, the changes are considered modest and cost-effective for the NHS, with expected advantages in reducing asthma attacks among children. However, MART will not be suitable for all children, and there are recommendations in place for those who are unable to manage the MART regimen, which aligns with current practices.   \n",
       "\n",
       "                                                                                                                                                                                        Source chunk (A) preview  \n",
       "0  blood pr essur e to lower tar gets in people wit h hyper tension (including t hose wit h type  2 \\ndiabet es). The updat ed guideline mak es new r ecommendations in t hese ar eas, based on \\nthe evidenc...  \n",
       "1  64 there was no clinically useful eff ect of t he monit oring in eit her adult s or childr en. The \\ncommitt ee not ed that t he int erventions w ere comple x, as t hey assessed t he eff ects not \\njust...  \n",
       "2  Agency using t he Yellow Car d Scheme . \\nLocal commissioners and pr oviders of healt hcare have a responsibility t o enable t he \\nguideline t o be applied when individual pr ofessionals and people usi...  \n",
       "3  prematur e morbidity and mor tality in t he w orld. It is a major risk f actor for str oke, \\nmyocardial inf arction, hear t failure, chr onic kidne y disease, cognitiv e decline and \\nprematur e deat h...  \n",
       "4  applies her e. The r ecommendations ar e not based on a specific e vidence sear ch, but t he \\ncommitt ee not ed that people in t he MART studies r eview ed for recommendations 1 .7.3 to \\n1.7.6 (see t ...  "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "rows = []\n",
    "\n",
    "for qa_a, qa_b in zip(results_a, results_b):\n",
    "    rows.append({\n",
    "        \"Question\": qa_a[\"question\"],\n",
    "        \"Answer A (BGE + config A)\": qa_a[\"answer\"],\n",
    "        \"Answer B (OpenAI + config B)\": qa_b[\"answer\"],\n",
    "        \"Source chunk (A) preview\": qa_a[\"chunk\"][:200] + \"...\"\n",
    "    })\n",
    "\n",
    "df_comparison = pd.DataFrame(rows)\n",
    "display(df_comparison)"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.1"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
